Physicians need to be aware of isotretinoin-induced acne fulminans, which can cause joint pain, fever, and eruptive, scarring acne lesions. Dr. Guy F. Webster discusses treatment and how to predict patients who may be at risk.
Dr. Webster spoke at the Hawaii Dermatology Seminar, sponsored by the Skin Disease Education Foundation. SDEF and this news organization are owned by Elsevier. (Dr. Webster disclosed the following potential conflicts of interest: Allergan, Amgen, Astellas, Aventis, Cipher, Cutanea, coria, Dermik, Galderma, Ortho, Johnson & Johnson, GSK, Xoma, Micrologix, Medicis, Ranbaxy, Skin Medica, Merck, Wyeth, Bristol-Myers, Stiefel, Onset, Valocor, Graceway, Nitricbio.)